✨ New Investment Opportunity: Transforming Epilepsy Care 🙇

Invest in Eysz to accelerate personalized treatments with improved patient outcomes for 70M+ epilepsy patients worldwide.

continue reading >

Congratulations, Echo!

Congratulations to our portfolio company Echo on their acquisition by CELLINK!

continue reading >

Why I Founded Bioverge: My Mission to Democratize Healthcare Investment Opportunities

Watch our CEO, Neil Littman, share the story that inspired him to found Bioverge.

continue reading >

The Bioverge Podcast: Advancing a Pipeline of Off-The-Shelf Cell Therapies

Brian Culley, CEO of Lineage Cell Therapeutics, sits down with Neil to discuss his company’s efforts to develop off-the-shelf cell therapies to treat degenerative retinal disease, spinal cord injury, and cancer.

continue reading >

The Bioverge Podcast: Weighing the Strengths and Weakness of Various COVID-19 Vaccines

Craig Laferrière head of vaccine development for Novateur Ventures, joins Neil to discuss the relative strengths and weaknesses of the different COVID-19 vaccines in use and in development.

continue reading >

Investment Opportunity, You Can Now Invest In Bioverge!

The Bioverge Reg CF Offering is Officially Live 🎊 and Accepting Investments!

continue reading >

Investing with Impact

Impact investing is both financially and socially rewarding, providing benefits to the individual investor and the world at large.

continue reading >

Diversifying in Healthcare Venture Capital

A brief explanation of the importance of diversification in and the unique characteristics of healthcare venture capital investment.

continue reading >

Angel Investing 101: What it is and How to Get Started

Angel Investing defined: A basic guide to help individual investors understand this new opportunity.

continue reading >

Reimagining Artificial Organs: IVIVA Medical

Even in our modern age of medical miracles, the prognosis and treatments for end-stage organ failure are still woefully inadequate. IVIVA Medical is on course to change all that.

continue reading >
Health + Tech, Investing, Startups

✨ New Investment Opportunity: Transforming Epilepsy Care 🙇

Invest in Eysz to accelerate personalized treatments with improved patient outcomes for 70M+ epilepsy patients worldwide.

Continue Reading >
Health + Tech, Investing, Startups

Congratulations, Echo!

Congratulations to our portfolio company Echo on their acquisition by CELLINK!

Continue Reading >
Health + Tech, Investing, Media

Why I Founded Bioverge: My Mission to Democratize Healthcare Investment Opportunities

Watch our CEO, Neil Littman, share the story that inspired him to found Bioverge.

Continue Reading >
Media

The Bioverge Podcast: Advancing a Pipeline of Off-The-Shelf Cell Therapies

Brian Culley, CEO of Lineage Cell Therapeutics, sits down with Neil to discuss his company’s efforts to develop off-the-shelf cell therapies to treat degenerative retinal disease, spinal cord injury, and cancer.

Continue Reading >
Media

The Bioverge Podcast: Weighing the Strengths and Weakness of Various COVID-19 Vaccines

Craig Laferrière head of vaccine development for Novateur Ventures, joins Neil to discuss the relative strengths and weaknesses of the different COVID-19 vaccines in use and in development.

Continue Reading >
Health + Tech, Investing, Press

Investment Opportunity, You Can Now Invest In Bioverge!

The Bioverge Reg CF Offering is Officially Live 🎊 and Accepting Investments!

Continue Reading >
Investing

Investing with Impact

Impact investing is both financially and socially rewarding, providing benefits to the individual investor and the world at large.

Continue Reading >
Investing

Diversifying in Healthcare Venture Capital

A brief explanation of the importance of diversification in and the unique characteristics of healthcare venture capital investment.

Continue Reading >
Investing

Angel Investing 101: What it is and How to Get Started

Angel Investing defined: A basic guide to help individual investors understand this new opportunity.

Continue Reading >
Health + Tech

Reimagining Artificial Organs: IVIVA Medical

Even in our modern age of medical miracles, the prognosis and treatments for end-stage organ failure are still woefully inadequate. IVIVA Medical is on course to change all that.

Continue Reading >
Prev Next